These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28595039)

  • 41. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
    Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
    FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of amyloid beta in lipid homeostasis.
    Grösgen S; Grimm MO; Friess P; Hartmann T
    Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. From acetylcholine to amyloid: neurotransmitters and the pathology of Alzheimer's disease.
    Nitsch RM
    Neurodegeneration; 1996 Dec; 5(4):477-82. PubMed ID: 9117566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP.
    García-González L; Pilat D; Baranger K; Rivera S
    Front Aging Neurosci; 2019; 11():244. PubMed ID: 31607898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease.
    Barger SW; Smith-Swintosky VL; Rydel RE; Mattson MP
    Ann N Y Acad Sci; 1993 Sep; 695():158-64. PubMed ID: 8239276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Metalloprotease Meprin β Is an Alternative β-Secretase of APP.
    Becker-Pauly C; Pietrzik CU
    Front Mol Neurosci; 2016; 9():159. PubMed ID: 28105004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing.
    Uddin MS; Kabir MT; Jeandet P; Mathew B; Ashraf GM; Perveen A; Bin-Jumah MN; Mousa SA; Abdel-Daim MM
    Oxid Med Cell Longev; 2020; 2020():7039138. PubMed ID: 32411333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of APP processing. Potential for the therapeutical reduction of brain amyloid burden.
    Nitsch RM; Wurtman RJ; Growdon JH
    Ann N Y Acad Sci; 1996 Jan; 777():175-82. PubMed ID: 8624081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.
    Brunholz S; Sisodia S; Lorenzo A; Deyts C; Kins S; Morfini G
    Exp Brain Res; 2012 Apr; 217(3-4):353-64. PubMed ID: 21960299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease.
    Gandy S; Caporaso G; Buxbaum J; Frangione B; Greengard P
    Neurobiol Aging; 1994; 15(2):253-6. PubMed ID: 7838304
    [No Abstract]   [Full Text] [Related]  

  • 51. Normal processing of the Alzheimer's disease amyloid beta protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives.
    Estus S; Golde TE; Younkin SG
    Ann N Y Acad Sci; 1992 Dec; 674():138-48. PubMed ID: 1288359
    [No Abstract]   [Full Text] [Related]  

  • 52. APP Receptor? To Be or Not To Be.
    Deyts C; Thinakaran G; Parent AT
    Trends Pharmacol Sci; 2016 May; 37(5):390-411. PubMed ID: 26837733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral cells as an investigational tool for Alzheimer's disease.
    Govoni S; Gasparini L; Racchi M; Trabucchi M
    Life Sci; 1996; 59(5-6):461-8. PubMed ID: 8761334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New insights into serotonin 5-HT4 receptors : a novel therapeutic target for Alzheimer's disease?
    Maillet M; Robert SJ; Lezoualc'h F
    Curr Alzheimer Res; 2004 May; 1(2):79-85. PubMed ID: 15975071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo.
    Jefferson T; Čaušević M; auf dem Keller U; Schilling O; Isbert S; Geyer R; Maier W; Tschickardt S; Jumpertz T; Weggen S; Bond JS; Overall CM; Pietrzik CU; Becker-Pauly C
    J Biol Chem; 2011 Aug; 286(31):27741-50. PubMed ID: 21646356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer's Disease? A Systematic Review.
    Carbone MG; Pagni G; Tagliarini C; Marazziti D; Pomara N
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. β-Amyloid precursor protein (APP) and the human diseases.
    Nguyen KV
    AIMS Neurosci; 2019; 6(4):273-281. PubMed ID: 32341983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of neuronal degeneration and preventative approaches: quickening the pace of AD research.
    Mattson MP
    Neurobiol Aging; 1994; 15 Suppl 2():S121-5. PubMed ID: 7700435
    [No Abstract]   [Full Text] [Related]  

  • 59. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration.
    van Dijk G; van Heijningen S; Reijne AC; Nyakas C; van der Zee EA; Eisel UL
    Front Neurosci; 2015; 9():173. PubMed ID: 26041981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation.
    Stewart KL; Radford SE
    Biophys Rev; 2017 Aug; 9(4):405-419. PubMed ID: 28631243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.